The Case Against Capsulectomies When Removing Silicone Breast Implants

T. Brown
{"title":"The Case Against Capsulectomies When Removing Silicone Breast Implants","authors":"T. Brown","doi":"10.1177/07488068221088114","DOIUrl":null,"url":null,"abstract":"Requests for removal of silicone breast implants are increasingly common. Often patients request a capsulectomy in either a total or “en bloc” form. Capsulectomy adds time, cost, and morbidity to removal of implant procedures. This article examines the reasoning given by practitioners for undertaking the procedure, and reviews the literature to examine the validity of those arguments. Except where pathology of the capsule is demonstrable (Breast implant related anaplastic large cell lymphoma, BIR-ALCL), there is currently no indication for prophylactic removal of capsules following removal of breast implants. Given the potential risks, and lack of evidence for the procedure, both patient and surgeons should be aware of the potential consequences.","PeriodicalId":297650,"journal":{"name":"The American Journal of Cosmetic Surgery","volume":"40 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American Journal of Cosmetic Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/07488068221088114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Requests for removal of silicone breast implants are increasingly common. Often patients request a capsulectomy in either a total or “en bloc” form. Capsulectomy adds time, cost, and morbidity to removal of implant procedures. This article examines the reasoning given by practitioners for undertaking the procedure, and reviews the literature to examine the validity of those arguments. Except where pathology of the capsule is demonstrable (Breast implant related anaplastic large cell lymphoma, BIR-ALCL), there is currently no indication for prophylactic removal of capsules following removal of breast implants. Given the potential risks, and lack of evidence for the procedure, both patient and surgeons should be aware of the potential consequences.
硅胶乳房植入物移除时反对包膜切除术的案例
要求移除硅胶乳房植入物越来越普遍。患者通常要求进行全囊切除或整体切除。荚膜切除术增加了时间、成本和发病率。本文考察了从业人员进行该程序的推理,并回顾了文献,以检验这些论点的有效性。除了病理证明的胶囊(乳房植入物相关间变性大细胞淋巴瘤,birl - alcl),目前没有指征在乳房植入物移除后预防性移除胶囊。考虑到潜在的风险,以及手术证据的缺乏,患者和外科医生都应该意识到潜在的后果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信